Open Access
Open access
Elsevier
Clinical Parkinsonism & Related Disorders
,  volume 11 ,  pages 100286

Acceptability of and attitudes to the therapeutic use of cannabis and cannabidiol in people with Parkinson’s disease: A French survey

Tangui Barré 1, 2
, 
Géraldine Cazorla 1, 2
, 
Vincent Di Beo 1
, 
Fabienne Lopez 3, 4
, 
Lise Radoszycki 5
, 
Gwenaëlle Maradan 6
, 
Christelle Baunez 7
, 
Patrizia Carrieri 1
1
 
2
 
3
 
Principes Actifs, Lieusaint, France. | 
4
 
Principes Actifs, Lieusaint, France | 
5
 
Carenity, Paris, France. | 
6
 
ORS PACA, Southeastern Health Regional Observatory, Marseille, France. | 
7
 
INT - Institut de Neurosciences de la Timone (Faculté de Médecine - Bâtiment Neurosciences 27, Bd Jean Moulin - 13385 Marseille Cedex 05 - France) | 
Publication type: Journal Article
Publication date: 2024-11-20
Elsevier
scimago Q3
wos Q3
SJR: 0.626
CiteScore: 3.0
Impact factor: 1.8
ISSN: 25901125
Abstract
IntroductionCannabis and cannabidiol (CBD) may potentially alleviate symptoms and improve the quality of life of people with Parkinson’s disease (PD), although clinical results to date have provided conflicting evidence. In France, cannabis use is illegal outside the current restricted medical cannabis experimental framework which does not include PD as an eligible condition. In contrast, CBD products are legal and are easily available. We aimed to evaluate the acceptability of therapeutic cannabis and CBD use, and to assess cannabinoid-related attitudes among people with PD in France, with a view to assessing the potential inclusion of medical cannabinoids in PD treatment options.
Found 
Found 

Top-30

Journals

1
Parkinson's Disease
Parkinson's Disease, 1, 100%
Parkinson's Disease
1 publication, 100%
1

Publishers

1
Hindawi Limited
Hindawi Limited, 1, 100%
Hindawi Limited
1 publication, 100%
1
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
1
Share
Cite this
GOST |
Cite this
GOST Copy
Barré T. et al. Acceptability of and attitudes to the therapeutic use of cannabis and cannabidiol in people with Parkinson’s disease: A French survey // Clinical Parkinsonism & Related Disorders. 2024. Vol. 11. p. 100286.
GOST all authors (up to 50) Copy
Barré T., Cazorla G., Di Beo V., Lopez F., Radoszycki L., Maradan G., Baunez C., Carrieri P. Acceptability of and attitudes to the therapeutic use of cannabis and cannabidiol in people with Parkinson’s disease: A French survey // Clinical Parkinsonism & Related Disorders. 2024. Vol. 11. p. 100286.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.prdoa.2024.100286
UR - https://linkinghub.elsevier.com/retrieve/pii/S2590112524000574
TI - Acceptability of and attitudes to the therapeutic use of cannabis and cannabidiol in people with Parkinson’s disease: A French survey
T2 - Clinical Parkinsonism & Related Disorders
AU - Barré, Tangui
AU - Cazorla, Géraldine
AU - Di Beo, Vincent
AU - Lopez, Fabienne
AU - Radoszycki, Lise
AU - Maradan, Gwenaëlle
AU - Baunez, Christelle
AU - Carrieri, Patrizia
PY - 2024
DA - 2024/11/20
PB - Elsevier
SP - 100286
VL - 11
PMID - 39687323
SN - 2590-1125
ER -
BibTex
Cite this
BibTex (up to 50 authors) Copy
@article{2024_Barré,
author = {Tangui Barré and Géraldine Cazorla and Vincent Di Beo and Fabienne Lopez and Lise Radoszycki and Gwenaëlle Maradan and Christelle Baunez and Patrizia Carrieri},
title = {Acceptability of and attitudes to the therapeutic use of cannabis and cannabidiol in people with Parkinson’s disease: A French survey},
journal = {Clinical Parkinsonism & Related Disorders},
year = {2024},
volume = {11},
publisher = {Elsevier},
month = {nov},
url = {https://linkinghub.elsevier.com/retrieve/pii/S2590112524000574},
pages = {100286},
doi = {10.1016/j.prdoa.2024.100286}
}
Profiles